Hou Y, Ye J, Qin K, Cui L, Chung S, Chapla D
bioRxiv. 2025; .
PMID: 39868097
PMC: 11761414.
DOI: 10.1101/2025.01.12.632650.
Wang K, Hsu R
Antibodies (Basel). 2024; 13(4).
PMID: 39449330
PMC: 11503282.
DOI: 10.3390/antib13040088.
Liu J, Chang X, Manji L, Xu Z, Xiao W
Front Pharmacol. 2024; 15:1442196.
PMID: 39351098
PMC: 11439703.
DOI: 10.3389/fphar.2024.1442196.
Chen S, Hu S, Lin Y, Liao W, Yang J
Int J Mol Sci. 2024; 25(17).
PMID: 39273519
PMC: 11395125.
DOI: 10.3390/ijms25179572.
Agbakwuru D, Wetzel S
Results Probl Cell Differ. 2024; 73:87-129.
PMID: 39242376
PMC: 11784324.
DOI: 10.1007/978-3-031-62036-2_5.
RANK in cancer-associated fibroblasts: A valuable prognostic determinant for metastasis in early-stage breast cancer patients.
Giorello M, Borzone F, Mora M, Padin M, Wernicke A, Labovsky V
Cancer Biomark. 2024; 41(2):115-132.
PMID: 39240628
PMC: 11492045.
DOI: 10.3233/CBM-230523.
Prevalence and diagnostic significance of p16, p53 expression in lichen planus as a potential premalignant lesion in oral squamous cell carcinoma.
Sridharan N, Nagalingam S, Vidhya P, Viswanathan P
J Oral Maxillofac Pathol. 2024; 28(1):56-61.
PMID: 38800439
PMC: 11126256.
DOI: 10.4103/jomfp.jomfp_427_23.
Screening for metastasis-related genes in mouse melanoma cells through sequential tail vein injection.
Hao Q, Dong R, Bai W, Chang D, Yao X, Zhang Y
Biophys Rep. 2024; 10(1):15-21.
PMID: 38737474
PMC: 11079599.
DOI: 10.52601/bpr.2023.230043.
PCSK5 downregulation promotes the inhibitory effect of andrographolide on glioblastoma through regulating STAT3.
Gong H, Yang X, An L, Zhang W, Liu X, Shu L
Mol Cell Biochem. 2024; 480(1):521-533.
PMID: 38553549
DOI: 10.1007/s11010-024-04977-3.
Expression of overall survival-EMT-immune cell infiltration genes predict the prognosis of glioma.
Zheng L, He J, Zhao K, Pan Y, Liu W
Noncoding RNA Res. 2024; 9(2):407-420.
PMID: 38511063
PMC: 10950607.
DOI: 10.1016/j.ncrna.2024.02.003.
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression.
Strippoli R, Niayesh-Mehr R, Adelipour M, Khosravi A, Cordani M, Zarrabi A
Cancers (Basel). 2024; 16(4).
PMID: 38398197
PMC: 10886827.
DOI: 10.3390/cancers16040807.
Forces at play: exploring factors affecting the cancer metastasis.
Riaz F, Zhang J, Pan F
Front Immunol. 2024; 15:1274474.
PMID: 38361941
PMC: 10867181.
DOI: 10.3389/fimmu.2024.1274474.
Significance of tumour budding and invasive characteristics in grading of oral squamous cell carcinoma.
Selvaraj F, Joseph A, Pillai V, Ramani P, Pazhani J, Mony V
J Oral Maxillofac Pathol. 2024; 27(4):642-648.
PMID: 38304506
PMC: 10829472.
DOI: 10.4103/jomfp.jomfp_410_23.
Evolutionary reversion in tumorigenesis.
Nagahata Y, Kawamoto H
Front Oncol. 2023; 13:1282417.
PMID: 38023242
PMC: 10662060.
DOI: 10.3389/fonc.2023.1282417.
Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics.
Li L, Zheng J, Oltean S
Genes (Basel). 2023; 14(11).
PMID: 38002944
PMC: 10671305.
DOI: 10.3390/genes14112001.
An Observatory for the Oncogene: A Guide for Targeted Therapies.
Altintas D, Comoglio P
Cancers (Basel). 2023; 15(18).
PMID: 37760640
PMC: 10526818.
DOI: 10.3390/cancers15184672.
and epithelial mesenchymal transition in human gastric cancers: An update of the literature.
Jamal Eddin T, Nasr S, Gupta I, Zayed H, Moustafa A
Heliyon. 2023; 9(8):e18945.
PMID: 37609398
PMC: 10440535.
DOI: 10.1016/j.heliyon.2023.e18945.
Voltage-gated sodium channels: from roles and mechanisms in the metastatic cell behavior to clinical potential as therapeutic targets.
Sanchez-Sandoval A, Hernandez-Plata E, Gomora J
Front Pharmacol. 2023; 14:1206136.
PMID: 37456756
PMC: 10348687.
DOI: 10.3389/fphar.2023.1206136.
Multiperspective quantitative tumor-stroma ratio reveals histological areas associated with poor outcomes in oral squamous cell carcinoma.
Wang S, Si Q, Wu Y, Sun Y, Zhang W, Huang X
Cancer Med. 2023; 12(11):12161-12172.
PMID: 37184217
PMC: 10278530.
DOI: 10.1002/cam4.5909.
Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal "unity of ecology and evolution" pathological ecosystem.
Luo W
Theranostics. 2023; 13(5):1607-1631.
PMID: 37056571
PMC: 10086202.
DOI: 10.7150/thno.82690.